AIRS

AirSculpt Technologies, Inc. NASDAQ Listed Oct 29, 2021

Healthcare ·Medical - Care Facilities ·US · elitebodysculpture.com

$3.46

Mkt Cap $244.1M

52w Low $1.51 18.6% of range 52w High $12.00

50d MA $2.57 200d MA $4.61

P/E (TTM) -17.5x

EV/EBITDA 159.6x

P/B 2.3x

Debt/Equity 0.9x

ROE -13.3%

P/FCF 173.0x

RSI (14) —

ATR (14) —

Beta 2.27

50d MA $2.57

200d MA $4.61

Avg Volume 2.6M

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.

SIC Code

8011

CIK (SEC)

1870940

Phone

786 709 9690

400 Alton Road · Miami Beach, FL 33139 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 2, 2026	BMO	-0.03	0.02	+180.0%	2.73	-5.5%	+16.1%	+13.6%	+7.7%	-0.4%	-0.7%	—
Nov 7, 2025	BMO	-0.01	-0.04	-300.0%	10.49	-30.4%	-41.7%	-39.6%	-45.0%	-41.8%	-45.5%	—
Aug 1, 2025	BMO	0.02	0.02	+0.0%	6.61	-16.8%	-10.4%	-8.8%	-8.9%	-7.0%	-6.2%	—
May 2, 2025	BMO	-0.03	-0.02	+33.3%	2.26	+26.5%	+33.6%	+7.5%	+1.8%	+13.3%	+25.2%	—
Mar 14, 2025	BMO	0.02	-0.08	-500.0%	2.94	-13.6%	-2.7%	-10.5%	-11.9%	+1.7%	-4.4%	—
Nov 8, 2024	BMO	-0.01	-0.02	-100.0%	7.19	+8.3%	+20.7%	+15.9%	+11.0%	+3.1%	-3.2%	—
Aug 9, 2024	BMO	0.13	0.09	-30.8%	3.94	-18.8%	+1.0%	-12.9%	-6.3%	-4.8%	-1.3%	—
May 10, 2024	BMO	0.08	0.03	-62.5%	5.39	-6.3%	-12.1%	-13.4%	-15.4%	-17.3%	-19.9%	—
Feb 27, 2024	BMO	0.11	0.01	-90.9%	6.31	-13.5%	-2.1%	-4.1%	+0.0%	-0.5%	-5.5%	—
Nov 9, 2023	BMO	0.09	0.05	-44.4%	6.18	+1.8%	-9.1%	-9.7%	-18.8%	-9.4%	-16.7%	—
Aug 11, 2023	BMO	0.15	0.13	-13.3%	7.86	-1.0%	-1.8%	-1.8%	-0.1%	+0.5%	-3.6%	—
May 12, 2023	BMO	0.05	0.10	+100.0%	4.89	+24.1%	+37.4%	+40.5%	+39.9%	+49.1%	+64.0%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 31	Leerink Partners	Maintains	Market Perform → Market Perform	—	$2.29	$2.20	-3.9%	+2.2%	-6.1%	-8.3%	-13.5%	-13.5%
Jan 17	Piper Sandler	Maintains	Neutral → Neutral	—	$4.93	$4.91	-0.4%	+8.1%	+7.3%	+2.8%	+6.7%	+3.7%
Jan 6	Piper Sandler	Maintains	Neutral → Neutral	—	$5.85	$5.76	-1.5%	+2.2%	+3.4%	+3.1%	+2.2%	-18.1%
May 14	Leerink Partners	Downgrade	Outperform → Market Perform	—	$4.67	$4.75	+1.7%	-2.4%	-4.5%	-7.5%	-0.2%	-7.7%
Nov 16	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$5.15	$5.17	+0.4%	-3.1%	-4.1%	+6.8%	+6.8%	+5.4%
Aug 22	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$7.67	$7.79	+1.6%	-2.1%	+4.6%	+1.3%	+3.4%	+3.9%
Aug 21	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$7.82	$7.88	+0.8%	-1.9%	-4.0%	+2.6%	-0.6%	+1.4%
Aug 1	Raymond James	Maintains	Outperform → Outperform	—	$9.07	$9.04	-0.3%	+0.6%	-3.6%	-1.3%	-3.5%	-4.2%
Mar 13	Raymond James	Maintains	Outperform → Outperform	—	$4.40	$4.32	-1.8%	+4.3%	+9.5%	+12.7%	+9.5%	+7.5%
Jan 17	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$4.98	$4.97	-0.2%	-6.0%	-7.8%	-1.2%	+0.8%	+6.6%
Nov 15	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$2.70	$2.76	+2.2%	+14.4%	+30.4%	+22.2%	+26.3%	+16.3%
Nov 14	Raymond James	Maintains	Outperform → Outperform	—	$3.28	$3.16	-3.7%	-17.7%	-5.8%	+7.3%	+0.6%	+4.0%
Nov 14	SVB Leerink	Maintains	Outperform → Outperform	—	$3.28	$3.16	-3.7%	-17.7%	-5.8%	+7.3%	+0.6%	+4.0%
Aug 24	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$9.81	$9.86	+0.5%	+0.8%	-6.0%	-8.8%	-8.9%	-10.1%
Jun 16	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$8.17	$7.59	-7.1%	-22.3%	-26.8%	-22.9%	-19.2%	-19.2%
Mar 14	SVB Leerink	Maintains	Outperform → Outperform	—	$13.28	$13.64	+2.7%	-10.8%	-5.9%	-2.6%	+2.6%	+4.8%

Data updated apr 24, 2026 4:58pm · Source: massive.com